Strategic Investments Genesis MedTech Group recently secured a $25M equity investment from Edwards, signaling strong investor confidence and potential for accelerated product development and market expansion.

AI in Surgery Active collaboration with NUHS clinicians to develop AI projects in surgery presents opportunities to tailor surgical devices and software, aligning with clinical requirements and proving adoption potential in hospitals.

Robotics Portfolio Launch of the OMNIBOT robotic-assisted surgical system expands Genesis’ robotics footprint and creates cross-sell opportunities for accessories, training, and service contracts with surgical centers.

Strategic Partnerships Existing partnerships with Silk Road Medical and ongoing joint initiatives position Genesis to offer integrated carotid, vascular, and interventional solutions, enabling bundled procurement conversations.

Regional Focus Headquartered in Singapore with a global footprint and collaborations with NUHS, Genesis is well-placed to pursue Asia-Pacific growth, regulatory-ready products, and hospital-network deals in high-potential markets.